Cyto earnings

WebApr 13, 2024 · Altamira Therapeutics ( NASDAQ:CYTO – Get Rating) and Viracta Therapeutics ( NASDAQ:VIRX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, … WebView the latest Altamira Therapeutics Ltd. (CYTO) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Altamira Therapeutics Ltd. (CYTO) Earnings Report

WebAltamira Therapeutics Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile. WebCYTOW Price/Earnings & PEG Ratios Information is currently not available; this data is based on analyst coverage. Price/Earnings Ratio label value Forecast P/E Growth Rates label value PEG... how many weeks until 6/21/2023 https://directedbyfilms.com

Earnings Whisper Number for CYTO: Altamira Therapeutics

WebNov 30, 2024 · Altamira Therapeutics (CYTO) reports earnings on 11/30/2024. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. … WebAltamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets ... WebAltamira Therapeutics Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. CYTO updated stock price target summary. Dow Jones, a News Corp company … how many weeks until 6/1/2023

Altamira Therapeutics Ltd. Warrant (CYTOW) Price/Earnings

Category:Altamira Therapeutics (CYTO) Shareholders Equity (Quarterly) - Zacks.com

Tags:Cyto earnings

Cyto earnings

CYTO Altamira Therapeutics Ltd. Analyst Estimates & Rating – WSJ

WebEarnings for Altamira Therapeutics (CYTO) Earnings in 2024 (TTM): -$11.57 M According to Altamira Therapeutics 's latest financial reports the company's current earnings (TTM) are -$11.57 M . WebFeb 24, 2024 · Cyclo Therapeutics, Inc. (CYTH) latest earnings report: revenue, EPS, surprise, history, news and analysis.

Cyto earnings

Did you know?

WebFind the latest Earnings Report Date for Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) (CYTO) at Nasdaq.com. Web2 days ago · Altamira Therapeutics Ltd. (CYTO) is up over 80% at $2.38. Rosecliff Acquisition Corp I (RCLF) is up over 22% at $12.85. Horizon Acquisition Corporation II …

WebAltamira Therapeutics (CYTO) will release its next earnings report on Aug 17, 2024. In the last quarter Altamira Therapeutics reported ― EPS in relation to ― expected by the market. Web2 days ago · View All Zacks #1 Ranked Stocks. Altamira Therapeutics (CYTO) Quote Overview » More Research » Altamira Therapeutics (CYTO) Price Target Stock Forecast. Trades from $ 1.

WebApr 12, 2024 · A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Altamira Therapeutics Ltd. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CYTO has a 100% Sell on average for the short term. WebOct 21, 2024 · Altamira Therapeutics Ltd (CYTO) $1.84 0.21 (12.88%) 16:00 EDT CYTO Stock Quote Delayed 30 Minutes Why Is Altamira Therapeutics (CYTO) Stock Up 70% Today? By David Moadel, InvestorPlace...

WebMar 24, 2024 · When is Altamira Therapeutics's earnings date? Altamira Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 11th, 2024 based off last year's report dates. Learn more on …

WebAbout Earnings Date. Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment ... how many weeks until 5/8/2023WebMar 24, 2024 · Altamira Therapeutics Ltd. (CYTO) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. … how many weeks until 4th may 2023WebApr 11, 2024 · Altamira Therapeutics - CYTO Competitors $1.42 +0.20 (+16.39%) (As of 03/30/2024 02:30 PM ET) Compare Today's Range $1.26 $1.46 50-Day Range $1.21 $5.18 52-Week Range $1.17 $43.00 Volume 165,553 shs Average Volume 584,425 shs Market Capitalization $1.66 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … how many weeks until 6/30/2023WebAltamira Therapeutics (CYTO) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Altamira Therapeutics’s upcoming earnings report date is Aug 17, 2024 which is in 135 days. How were Altamira Therapeutics’s earnings last quarter? Currently, no data ... how many weeks until 6th april 2023Web1 day ago · Detailed statistics for Altamira Therapeutics Ltd. (CYTO) stock, including valuation metrics, financial numbers, share information and more. ... Last Earnings Date … how many weeks until 6/5/2023WebCYTO Altamira Therapeutics Ltd. Analyst Estimates MarketWatch. Dow. 33,147.25. -73.55. -0.22%. S&P 500. 3,839.50. -9.78. how many weeks until 6th feb 2023WebApr 13, 2024 · CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company’s lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric … how many weeks until 6th june 2022